Text Size

Prognosis of Atypical Pituitary Adenomas

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Tohoku University.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Tohoku University
ClinicalTrials.gov Identifier:
NCT00473369
First received: May 14, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
  Purpose

Context: Pituitary adenoma is generally indolent, but an aggressive subtype called atypical adenoma has uncertain prognosis, and an unclear relationship between prognosis and morphology.

Objective: This study investigated the prognostic factors of this tumor. Design: Retrospective analysis. Setting: University and associated hospitals.


Condition
Pituitary Diseases

Study Type: Observational
Study Design: Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Retrospective

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Tohoku University:

Study Start Date: January 2001
Estimated Study Completion Date: May 2007
  Eligibility

Ages Eligible for Study:   12 Years to 74 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • pituitary adenomas of more than 3 % of Ki67 labeling index surgically treated at Tohoku university and associated hospital

Exclusion Criteria:

  • pituitary adenomas of less than 3 % of Ki-67 labeling index surgically treated at Tohoku university and associated hospital
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00473369

Sponsors and Collaborators
Tohoku University
Investigators
Principal Investigator: Yoshikazu Ogawa, M. D. Department of neurosurgery, Tohoku university
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00473369     History of Changes
Other Study ID Numbers: 1-2007.nsg.med.tohoku
Study First Received: May 14, 2007
Last Updated: May 14, 2007
Health Authority: Japan: Institutional Review Board

Keywords provided by Tohoku University:
atypical adenoma
Ki-67
p53
pituitary
prognosis

Additional relevant MeSH terms:
Pituitary Neoplasms
Pituitary Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Hypothalamic Neoplasms
Supratentorial Neoplasms
Brain Neoplasms
 Central Nervous System Neoplasms
Nervous System Neoplasms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Hypothalamic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 23, 2013